The Claim
In a mouse model of dihydrotestosterone-induced polycystic ovary syndrome, daily oral administration of the probiotic strain BL21 at a dose of 1 × 10⁹ colony-forming units for 8 weeks was associated with increased gut microbiota diversity and enrichment of beneficial bacterial genera, including Bifidobacterium, Lactobacillus, and Butyricicoccus, suggesting that microbial modulation may be a potential mechanism underlying the observed effects.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Giving a specific probiotic to mice with a condition like PCOS helped improve their gut bacteria, making it more diverse and increasing good types — which might be how it helps the body.
See the scientific wording
In a mouse model of DHT-induced PCOS, 8 weeks of daily oral BL21 supplementation at 1 × 10⁹ CFU was associated with increased gut microbiota diversity and enrichment of beneficial genera including Bifidobacterium, Lactobacillus, and Butyricicoccus, suggesting a potential mechanism through microbial modulation.
What the research says
1 studyThe study gave mice a specific probiotic for 8 weeks and found it improved gut bacteria, including good types like Bifidobacterium and Lactobacillus, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.